Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles

Traders abandon bets on loose monetary policy for the year, Europe warns inflation may reach 6.3%, gold continues to decline for multiple days.

US Stock Market Move | Oil stocks generally rose, Occidental Petroleum Corporation (OXY.US) up more than 3%.

Global bond markets suffered a significant sell-off, with the UK becoming a "hard-hit area." The market is betting that the central bank will prioritize tackling inflation.
Traders abandon bets on loose monetary policy for the year, Europe warns inflation may reach 6.3%, gold continues to decline for multiple days.

US Stock Market Move | Oil stocks generally rose, Occidental Petroleum Corporation (OXY.US) up more than 3%.

Global bond markets suffered a significant sell-off, with the UK becoming a "hard-hit area." The market is betting that the central bank will prioritize tackling inflation.

RECOMMEND

“Memory Price Surge” For 100 Days, Low‑End Smartphones Forced Into Decline
19/03/2026

Hong Kong Suddenly Becomes A New Destination For Middle Eastern Capital? Signs Of Increased Allocation Are Evident
19/03/2026

Memory Price Surge Persists For 100 Days, Forcing Low‑End Smartphones Toward Extinction
19/03/2026


